{"transactions":[{"id":2118099,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-14T21:46:38.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":325,"price":17.051,"value":5541.575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 325 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":30011,"source":{"system":"sec-edgar","filing":"0001209191-22-056891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919122056891/doc4.xml","form_type":"4"}},{"id":2273576,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-12T21:14:57.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":1125,"price":13.566,"value":15261.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 1,125 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":29686,"source":{"system":"sec-edgar","filing":"0001209191-22-028719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919122028719/doc4.xml","form_type":"4"}},{"id":2440202,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-07T16:52:03.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest one year after January 6, 2022 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":60000,"derivative":{"exercise_price":15.87,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-002426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919122002426/doc4.xml","form_type":"4"}},{"id":2440201,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-07T16:52:03.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":28561,"source":{"system":"sec-edgar","filing":"0001209191-22-002426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919122002426/doc4.xml","form_type":"4"}},{"id":2493344,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-29T21:49:30.000Z","date":"2021-11-26","kind":"purchase","acquired":true,"shares":750,"price":13.9,"value":10425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256.  The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934."}],"balance_after":18561,"source":{"system":"sec-edgar","filing":"0001209191-21-067068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121067068/doc4.xml","form_type":"4"}},{"id":2493343,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-29T21:49:30.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":700,"price":14.4,"value":10080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256.  The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934."}],"balance_after":17811,"source":{"system":"sec-edgar","filing":"0001209191-21-067068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121067068/doc4.xml","form_type":"4"}},{"id":2512930,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-15T16:16:01.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":458,"price":13.515,"value":6189.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 458 shares by the Reporting Person on November 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":17111,"source":{"system":"sec-edgar","filing":"0001209191-21-064447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121064447/doc4.xml","form_type":"4"}},{"id":2554503,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-01T20:00:24.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1574,"price":19.256,"value":30308.944,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021."}],"balance_after":16653,"source":{"system":"sec-edgar","filing":"0001209191-21-058607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121058607/doc4.xml","form_type":"4"}},{"id":2554502,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-01T20:00:24.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021.  On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 4,687 shares on September 29, 2021 and 4,688 shares on June 30, 2023."}],"balance_after":18227,"source":{"system":"sec-edgar","filing":"0001209191-21-058607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121058607/doc4.xml","form_type":"4"}},{"id":2716736,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-12T17:27:56.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":981,"price":14.62,"value":14342.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 981 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":8852,"source":{"system":"sec-edgar","filing":"0001209191-21-032139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121032139/doc4.xml","form_type":"4"}},{"id":2803417,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-08T19:42:33.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":1592,"price":18.65,"value":29690.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction."}],"balance_after":7871,"source":{"system":"sec-edgar","filing":"0001209191-21-018770","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121018770/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-28"}},{"id":2911081,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-11T17:32:21.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 7, 2021 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":75000,"derivative":{"exercise_price":19.19,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-003022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919121003022/doc4.xml","form_type":"4"}},{"id":2931511,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-28T16:12:16.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":1562,"price":18.65,"value":29131.3,"ownership":{"direct":true},"balance_after":7841,"source":{"system":"sec-edgar","filing":"0001209191-20-065167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919120065167/doc4.xml","form_type":"4"}},{"id":2931510,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-28T16:12:16.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":908,"price":18.55,"value":16843.4,"ownership":{"direct":true},"balance_after":6279,"source":{"system":"sec-edgar","filing":"0001209191-20-065167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919120065167/doc4.xml","form_type":"4"}},{"id":2984105,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-12T17:06:28.000Z","date":"2020-11-10","kind":"grant","acquired":true,"shares":1371,"price":15.266,"value":20929.686,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 1,371 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":5371,"source":{"system":"sec-edgar","filing":"0001209191-20-058035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919120058035/doc4.xml","form_type":"4"}},{"id":3311833,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-14T17:35:34.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 10, 2020 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":65000,"derivative":{"exercise_price":19.24,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-003338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919120003338/doc4.xml","form_type":"4"}},{"id":3418617,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & Communications"}}],"security":"Common Stock","published_at":"2019-09-10T19:19:50.000Z","date":"2019-09-06","kind":"purchase","acquired":true,"shares":2199,"price":11.87,"value":26102.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction reported was $11.87, and the range of prices were between $11.77 and $11.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-049092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919119049092/doc4.xml","form_type":"4"}},{"id":3418616,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":122430,"kind":"person","name":"Clements Ian","position":1,"cik":"0001780080","reported_name":"Clements Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance & Communications"}}],"security":"Common Stock","published_at":"2019-09-10T19:19:50.000Z","date":"2019-09-06","kind":"purchase","acquired":true,"shares":1801,"price":11.07,"value":19937.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $11.07, and the range of prices were between $10.70 and $11.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":1801,"source":{"system":"sec-edgar","filing":"0001209191-19-049092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780080/000120919119049092/doc4.xml","form_type":"4"}}]}